Article Abstract

The eligibility of primary tumor resection for de novo stage IV breast cancer patients

Authors: Tadahiko Shien

Abstract

There are many retrospective reports to indicate the survival benefit of primary tumor resection for de novo stage IV breast cancer. Moreover, several comprehensive reviews have described significant differences in survival time (hazard ratio of ~0.6) (1,2). However, retrospective reports include numerous biases.